BIOA

BioAge Labs, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-24

Figures on this page computed 2026-11-08 12:48 UTC

Last close

5.34USD

Market data, 2026-11-06

Except where said otherwise: 10-K for 2025, filed 2026-03-24

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001193125-26-120873
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-24
The filing itself
-104.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001193125-26-120873
Reported in
USD
- 10-K for 2025, filed 2026-03-24
- 10-K for 2025, filed 2026-03-24
- 10-K for 2025, filed 2026-03-24
- 10-Q for 2025, filed 2026-08-05
- 10-K for 2025, filed 2026-03-24
- 10-Q for 2025, filed 2026-08-05
The filing itself
-896.1%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-120873
Reported in
USD
- 10-K for 2025, filed 2026-03-24
- 10-K for 2025, filed 2026-03-24
The filing itself
-915.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001193125-26-120873
Reported in
USD
- 10-K for 2025, filed 2026-03-24
- 10-K for 2025, filed 2026-03-24
The filing itself
0.02Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001193125-26-120873
Reported in
USD
- 10-K for 2025, filed 2026-03-24
- 10-Q for 2025, filed 2026-08-05
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Margins is the furthest below its sector's middle: 0.06 against 0.23 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

2.00x

1.26x

1.58x

0.71x

0.48x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-06

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-24

Sales2.00x
Its own average over 2 years, 4.5M.
Profit1.26x
Its own average over 4 years, -63.8M.
Free cash flow1.58x
Its own average over 4 years, -52.0M.
Debt0.71x
Its own average over 4 years, 7.8M.
Price0.48x
Its own average over 3 years, 11. Market data, 2026-11-06

Sales is furthest from its own average, at 2.00 times.

Sales is 2.00 times its own 2-year average; Profit is 1.26 times its own 4-year average; Free cash flow is 1.58 times its own 4-year average; Debt is 0.71 times its own 4-year average; Price is 0.48 times its own 3-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-24

Sales against its own 2-year average2.00
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-120873
Reported in
USD
The filing itself
Profit against its own 4-year average1.26
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-120873
Reported in
USD
The filing itself
Free cash flow against its own 4-year average1.58
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-120873
Reported in
USD
The filing itself
Debt against its own 4-year average0.71
Source
filed
Statement
income
Fiscal year
2025
Accession
0001193125-26-120873
Reported in
USD
The filing itself
Price against its own 3-year average0.48Market data, 2026-11-06
Source
market
Taken on
2026-11-06
Reported in
USD